Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Intimation of Credit ratingmore...
Sumitomo Chemical India Limited has informed the Exchange about Credit Ratingmore...
Sumitomo Chemical Company Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of I...more...
As of March 2026 75.00% is owned by Foreign Promoters and 25.00% by Public. Institutional holds 12.39% (Insurance Companies 0.98%) and Non-I...more...
Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st March 2026more...
Sumitomo Chemical India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Sumitomo Chemical India Limited has informed the Exchange regarding Cessation of Mr Yoshihisa Inoue as Other of the company w.e.f. March 31 2026.more...
Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 - Change in Management Personnel.more...
Sumitomo Chemical India Limited has informed the Exchange about Schedule of meetmore...
Intimation of Schedule of Institutional Investors/Analyst meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulati...more...
Sumitomo Chemical India Limited has informed the Exchange about Investor Presentationmore...
Revised Investor Presentation - Quarter and Nine Months Ended 31st December 2025.more...
The company reported standalone net profit of Rs 74.83 crore for the quarter ended December 31 2025 as compared to Rs 84.31 crore in the sam...more...
Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2025.more...
Integrated Filing (Financial) for the quarter and nine months ended 31st December 2025.more...
Sumitomo Chemical India Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
As of December 2025 75.00% is owned by Foreign Promoters and 25.00% by Public. Institutional holds 12.02% (Insurance Companies 0.95%) and Non-Institu...more...
BOARD MEETINGS Company Name : Aakaar Medical Tech Date : 15-05-2026